ProcDNA participated in the Pharmaceutical Management Science Association (PMSA) Annual Conference 2026 in New Orleans, bringing together pharmaceutical, biotechnology, and analytics leaders to discuss how AI, data, and advanced analytics are reshaping decision-making across the life sciences industry.

Representing ProcDNA, engaged with industry leaders through insightful discussions, a podium presentation, and poster sessions focused on advancing AI-driven decision intelligence across commercial and medical functions.

At the conference, ProcDNA showcased practical applications of AI that help life sciences organizations move beyond isolated pilots to enterprise-scale adoption. The team's sessions highlighted how organizations can operationalize generative AI and agentic systems to improve content discoverability, strengthen field execution, accelerate insight generation, and enable faster, more informed business decisions.

The conference also provided an opportunity to exchange perspectives with industry peers on the evolving role of AI in commercial analytics, market access, medical affairs, and customer engagement. As organizations continue to invest in data-driven transformation, discussions reinforced the importance of combining deep domain expertise with scalable AI capabilities to deliver measurable business impact.

ProcDNA remains committed to helping life sciences organizations translate data into action through AI-powered solutions that enable smarter decision-making, improve operational efficiency, and accelerate commercial success.